The use of a modular metaphyseal-diaphyseal femoral stem in primary total hip arthroplasty is infrequent. We analyze 94 ESOP (Fournitures Hospitalieres, Heimsbrunn, France) cementless 2-piece modular stems after a minimum 5 years of follow-up. There were 2 aseptic femoral stem loosenings and no cases with thigh pain. Mean femoral canal filling was 90%. Radiographic ingrowth was obtained in 83 (P < .001). At 7 years, the survival rate for femoral aseptic loosening was 97.8% and no stem was at risk for revision (95% confidence interval, 94.8%-100%). This prosthesis provides good clinical results with absence of pain and excellent radiographic results. It is an option in femora with good bone quality. Femoral osteopenia and cortical widening were infrequent, and the modular metaphyseal-diaphyseal junction was not a problem in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arth.2007.10.012DOI Listing

Publication Analysis

Top Keywords

femoral stem
12
stem primary
8
primary total
8
total hip
8
hip arthroplasty
8
modular metaphyseal-diaphyseal
8
femoral
6
hydroxyapatite-coated modular
4
modular femoral
4
stem
4

Similar Publications

This report describes a medial calcar episiotomy with partial anterior transfemoral osteotomy of the proximal femur to aid in removal of a femoral component in setting of revision total hip arthroplasty through a direct anterior approach. Revision total hip arthroplasty is challenging, labor-intensive, and carries high complication rates. Previously described techniques such as extended trochanteric osteotomies can be utilized to facilitate removal of fixed femoral stems.

View Article and Find Full Text PDF

Introduction: Salvage arthroplasty for failed proximal femoral fracture fixation is a complex procedure. This involves the removal of the primary failed or broken implant followed by a hip joint replacement procedure. The complications and technical difficulties associated with these surgeries are often difficult to anticipate.

View Article and Find Full Text PDF

Osteoporosis is treated with oral and parenteral resorption inhibitors and parenteral osteogenic drugs. However, orally active small-molecule osteogenic drugs are not clinically available. Natural coumarin derivatives, such as osthole, exert osteoblastogenic effects.

View Article and Find Full Text PDF

Skeletal disorders pose significant challenges to health and quality of life, underscoring the critical need for innovative bone repair methods. Recent studies have spotlighted the promising role of extracellular vesicles (EVs) derived from bone marrow mesenchymal stem cells (BMSCs) in conjunction with biomimetic peptide (BP) WKYMVm (WK) for bone repair. This research leveraged a self-healing hydrogel as a carrier, effectively loading EVs and WK to enhance treatment efficacy.

View Article and Find Full Text PDF

Osteonecrosis of the femoral head can lead to end-stage osteoarthritis when left untreated. The incidence has been on the rise since the onset of the COVID-19 pandemic. Core decompression of the femoral head is usually the first line of surgical treatment when conservative options fail.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!